🇺🇸 FDA
Pipeline program

Lynparza 150 mg film-coated tablets, Lynparza 100 mg film-coated tablets, ART6043, ART6043, ART6043, ART6043, ART6043

ART6043C001

Phase 2 small_molecule active

Quick answer

Lynparza 150 mg film-coated tablets, Lynparza 100 mg film-coated tablets, ART6043, ART6043, ART6043, ART6043, ART6043 for Metastatic solid tumors, Advanced solid tumors is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Metastatic solid tumors, Advanced solid tumors
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials